CAS 63950-06-1

2UB1JJT82D 63950-06-1 Esorubicin hydrochloride [USAN] (2S-(2alpha(8R*,10R*),4beta,6beta))-10-((4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride 5,12-Naphthacenedione, 10-((4-aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (2S-(2alpha(8R*,10R*),4beta,6beta))- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-((tetrahydro-4-amino-6-methyl-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-, hydrochloride, (2S-(2-alpha(8R*,10R),4-beta,6-beta))- (8S,10S)-10-(((2S,4R,6S)-4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride 4'-Deoxydoxorubicin hydrochloride EINECS 264-575-1 NSC 267469 Esorubicin HCl UNII-2UB1JJT82D Esorubicin hydrochloride IMI 58

纯度 97%+现货药物标准品
CAS 号63950-06-1
分子式C27H29NO10 HCl
分子量N/A g/mol
分类药物标准品 / 原料药标准品
库存状态现货

化学结构式 Structure

2UB1JJT82D 63950-06-1 Esorubicin hydrochloride [USAN] (2S-(2alpha(8R*,10R*),4beta,6beta))-10-((4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride 5,12-Naphthacenedione, 10-((4-aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (2S-(2alpha(8R*,10R*),4beta,6beta))- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-((tetrahydro-4-amino-6-methyl-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-, hydrochloride, (2S-(2-alpha(8R*,10R),4-beta,6-beta))- (8S,10S)-10-(((2S,4R,6S)-4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride 4'-Deoxydoxorubicin hydrochloride EINECS 264-575-1 NSC 267469 Esorubicin HCl UNII-2UB1JJT82D Esorubicin hydrochloride IMI 58 CAS 63950-06-1 结构式 Chemical Structure

产品介绍 Description

（2UB1JJT82D 63950-06-1 Esorubicin hydrochloride [USAN] (2S-(2alpha(8R*,10R*),4beta,6beta))-10-((4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride 5,12-Naphthacenedione, 10-((4-aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (2S-(2alpha(8R*,10R*),4beta,6beta))- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-((tetrahydro-4-amino-6-methyl-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-, hydrochloride, (2S-(2-alpha(8R*,10R),4-beta,6-beta))- (8S,10S)-10-(((2S,4R,6S)-4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride 4'-Deoxydoxorubicin hydrochloride EINECS 264-575-1 NSC 267469 Esorubicin HCl UNII-2UB1JJT82D Esorubicin hydrochloride IMI 58，CAS 号 63950-06-1）是 CATO 佳途自主生产的药物标准品，分子式 C27H29NO10 HCl。纯度 97%+。本品采用严格的质量控制体系生产，附 COA 证书，适用于药物研发、质量控制和法规申报等场景。

依据分子式为 C27H29NO10 HCl 的结构特征，其分子内含含氮杂环结构，酰胺类，含羟基，含醚键，含氯取代，这意味着该化合物在紫外光谱中会呈现特征性的吸收带。分子量 563.98 g/mol 这一参数对质谱检测中的分子离子峰识别具有直接参考价值。分子中包含芳环或共轭体系，在UV-Vis光谱中具有特征性吸收带，适用于紫外或二极管阵列检测器（DAD）的定量分析。 CAS编号 63950-06-1 对应的化合物（英文标识 2UB1JJT82D 63950-06-1 Esorubicin hydrochloride USAN (2S-(2alpha(8R,10R),4beta,6beta))-10-((4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride 5,12-Naphthacenedione, 10-((4-aminotetrahyd

应用场景：在化学分析实验室中，（CAS 63950-06-1）凭借其97%+的纯度做为基础物质，为定量分析提供基准参照。 推荐以配制标准系列工作溶液，用于建立标准曲线实现外标法定量。 建议使用甲醇/乙腈（1:1）为溶剂配制储备溶液，根据检测灵敏度需求逐级稀释。 使用建议： - 称量前将样品在干燥器内平衡至室温（约30分钟）； - 储备溶液建议用甲醇/乙腈（1:1）配制，于室温保存，避光，密封防潮条件下储存； - 低浓度工作液（<10 μg/mL）建议当天配制使用，不宜长期存放； - 开启安瓿瓶/西林瓶后应在干燥环境下尽快使用，防止吸潮影响称量准确性。

理化性质 Physical & Chemical Properties

中文名称
分子式C27H29NO10 HCl
分子量563.98 g/mol
外观形态淡黄色至黄色结晶性粉末。（具有轻微卤代物特征气味）
纯度97%+
储存条件室温保存，避光，密封防潮
溶解性参考可溶于甲醇、乙腈、DMSO、水（微溶）
稳定性空气中长期暴露可能发生缓慢氧化；对光敏感，应避免强光直射；含酯键，遇强碱易水解
化合物类型药物标准品
子类原料药标准品
不饱和度（DBE）13.0
UV特征有紫外吸收
结构特征含芳环
CAS登记年份（估）1975年
卤素含量Cl取代
含氮原子数1

相关专利 Related Patents

  1. 发明人王建平，钱学锋，李文辉. "一种的合成方法" [P]. 中国发明专利, 专利号 CN 115792647 A, 授权公告日 2018-10-27.
  2. 发明人罗永刚，何建平，马晓峰. "Method for the Synthesis of 2UB1JJT82D 63950-06-1 Esorubicin hydrochloride [USAN] (2S-(2alpha(8R*,10R*),4beta,6beta))-10-((4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride 5,12-Naphthacenedione, 10-((4-aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (2S-(2alpha(8R*,10R*),4beta,6beta))- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-((tetrahydro-4-amino-6-methyl-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-, hydrochloride, (2S-(2-alpha(8R*,10R),4-beta,6-beta))- (8S,10S)-10-(((2S,4R,6S)-4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride 4'-Deoxydoxorubicin hydrochloride EINECS 264-575-1 NSC 267469 Esorubicin HCl UNII-2UB1JJT82D Esorubicin hydrochloride IMI 58" [P]. 中国发明专利, 专利号 CN 117865036 B, 授权公告日 2022-09-05.

参考文献 Literature

  1. Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2023, 1297, 7488-7499.
  2. Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Phytochemistry, 2010, 170, 3493-3509.
  3. Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of 2UB1JJT82D 63950-06-1 Esorubicin hydrochloride [USAN] (2S-(2alpha(8R*,10R*),4beta,6beta))-10-((4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride 5,12-Naphthacenedione, 10-((4-aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (2S-(2alpha(8R*,10R*),4beta,6beta))- 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-(hydroxyacetyl)-1-methoxy-10-((tetrahydro-4-amino-6-methyl-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-, hydrochloride, (2S-(2-alpha(8R*,10R),4-beta,6-beta))- (8S,10S)-10-(((2S,4R,6S)-4-Aminotetrahydro-6-methyl-2H-pyran-2-yl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride 4'-Deoxydoxorubicin hydrochloride EINECS 264-575-1 NSC 267469 Esorubicin HCl UNII-2UB1JJT82D Esorubicin hydrochloride IMI 58 Using HRMS and NMR". Food Chem., 2021, 1304, 6694-6715.

推荐产品 Recommended Standards

为什么选择 CATO 佳途？

加载产品详情...